Narasimhan; Chakravarthy Nachu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Narasimhan; Chakravarthy Nachu.The latest application filed is for "stable formulations of programmed death receptor 1 (pd-1) antibodies and methods of use thereof".

Company Profile

3.3.12

Narasimhan; Chakravarthy Nachu - Scotch Plains NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Stable Formulations Of Programmed Death Receptor 1 (pd-1) Antibodies And Methods Of Use Thereof App 20210380694 - Forrest, Jr.; William P. ; et al.	2021-12-09
Formulations Of Anti-rsv Antibodies And Methods Of Use Thereof App 20210324052 - Hashemi; Venus ; et al.	2021-10-21
Anti-human Pd-1 Antibody Crystals And Methods Of Use Thereof App 20210317215 - Reichert; Paul ; et al.	2021-10-14
Rapid Method To Predict Stabilities Of Pharmaceutical Compositions Containing Protein Therapeutics And Non-reducing Sugars App 20210236640 - De; Arnab ; et al.	2021-08-05
Stable Formulations Of Anti-tigit Antibodies Alone And In Combination With Programmed Death Receptor 1 (pd-1) Antibodies And Methods Of Use Thereof App 20200354453 - De; Arnab ; et al.	2020-11-12
Stable Formulations Of Anti-ctla4 Antibodies Alone And In Combination With Programmed Death Receptor 1 (pd-1) Antibodies And Met App 20200262922 - Bhattacharya; Soumendu ; et al.	2020-08-20
Stable Formulations Of Programmed Death Receptor 1 (pd-1) Antibodies And Methods Of Use Thereof App 20200147213 - Sharma; Manoj K. ; et al.	2020-05-14
Formulations Of Engineered Anti-il-10 Antibodies App 20190010224 - Narasimhan; Chakravarthy Nachu ; et al.	2019-01-10
Crystalline anti-human IL-23p19 antibodies Grant 9,803,010 - Reichert , et al. October 31, 2	2017-10-31
Stable formulations of antibodies to human programmed death receptor PD-1 and related treatments Grant 9,220,776 - Sharma , et al. December 29, 2	2015-12-29
Crystalline Anti-human Il-23 Antibodies App 20150147337 - Reichert; Paul ; et al.	2015-05-28
Stable Formulations Of Antibodies To Human Programmed Death Receptor Pd-1 And Related Treatments App 20140234296 - Sharma; Manoj K. ; et al.	2014-08-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.